Guaifenesin
- Product NDC
- 58602-810
- 11-digit product format
- 586020810
- Labeler code
- 58602
- Product ID
- 58602-810_e6952325-704d-4774-847c-02a6feb77434
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurohealth LLC
- Application
- ANDA210453
- Marketing category
- ANDA
- Marketing start
- 2019-10-21
- Substance
- GUAIFENESIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210453-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | ||
| A210453-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A210453-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A210453-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2019-10-21 | 782e0a99824c… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 600 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 636522 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e95b5292-cd6c-4737-9386-f9441fd1bc28 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58602-810-12 | Guaifenesin | 40 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 40 | 7 | |
| 58602-810-12 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 7 | |
| 58602-810-21 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 7 | |
| 58602-810-21 | Guaifenesin | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 7 | |
| 58602-810-38 | Guaifenesin | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 7 | |
| 58602-810-38 | Guaifenesin | 8 in 1 CARTON | TABLET, EXTENDED RELEASE | 8 | 7 | |
| 58602-810-73 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 7 | |
| 58602-810-73 | Guaifenesin | 20 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 20 | 7 | |
| 58602-810-96 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 7 | |
| 58602-810-96 | Guaifenesin | 20 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 20 | 7 | |
| 58602-810-97 | Guaifenesin | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 7 | |
| 58602-810-97 | Guaifenesin | 20 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 20 | 7 | |
| 58602-810-98 | Guaifenesin | 20 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 20 | 7 | |
| 58602-810-98 | Guaifenesin | 5 in 1 CARTON | TABLET, EXTENDED RELEASE | 5 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58602-810-97 | EA - Each | 58602-810 | de48e26f-a046-4003-ae9d-f749880526d1 | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 636522 | guaiFENesin 600 MG 12HR Extended Release Oral Tablet | PSN | e95b5292-cd6c-4737-9386-f9441fd1bc28 | 7 |
| 636522 | 12 HR guaifenesin 600 MG Extended Release Oral Tablet | SCD | e95b5292-cd6c-4737-9386-f9441fd1bc28 | 7 |
| 636522 | guaifenesin 600 MG 12 HR Extended Release Oral Tablet | SY | e95b5292-cd6c-4737-9386-f9441fd1bc28 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 58602-810-12 | 58602081012 | 1 BOTTLE in 1 CARTON (58602-810-12) / 40 TABLET, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2019-10-21 | 0000-00-00 | No | No | Current |
| 58602-810-21 | 58602081021 | 1 BOTTLE in 1 CARTON (58602-810-21) / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2019-10-21 | 0000-00-00 | No | No | Current |
| 58602-810-38 | 58602081038 | 8 BLISTER PACK in 1 CARTON (58602-810-38) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 8 blister pack | 2022-12-07 | No | No | Current | |
| 58602-810-73 | 58602081073 | 1 BOTTLE in 1 CARTON (58602-810-73) / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2019-10-21 | 0000-00-00 | No | No | Current |
| 58602-810-96 | 58602081096 | 1 BLISTER PACK in 1 CARTON (58602-810-96) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 1 blister pack | 2019-10-21 | 0000-00-00 | No | No | Current |
| 58602-810-97 | 58602081097 | 2 BLISTER PACK in 1 CARTON (58602-810-97) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 2 blister pack | 2019-10-21 | 0000-00-00 | No | No | Current |
| 58602-810-98 | 58602081098 | 5 BLISTER PACK in 1 CARTON (58602-810-98) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 5 blister pack | 2019-10-21 | 0000-00-00 | No | No | Current |